L-Anserine nitrate | CAS:10030-52-1

We serve L-Anserine nitrate CAS:10030-52-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
L-Anserine nitrate

Chemical Name:L-Anserine nitrate
CAS.NO:10030-52-1
Synonyms:L-Anserine nitrate
β-Alanyl-3-methyl-L-histidine nitrate
anserine nitrate
 
Physical and Chemical Properties:
Boiling Point 611.3ºC at 760mmHg
Melting Point 226-228ºC
Molecular Formula C10H17N5O6
Molecular Weight 303.272
Flash Point 323.5ºC
 
Specification:
Appearance:White to off-white powder
Assay:≥95.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:L-Anserine is a dipeptide found in most animal tissues. In model systems it is a potent antioxidant and scavener of hydroxyl radicals. It inhibits nonenzymatic protein glycation induced by aldose and ketose reducing sugars.



Contact us for information like L-Anserine nitrate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,anserine nitrate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,L-Anserine nitrate Use and application,L-Anserine nitrate technical grade,usp/ep/jp grade.


Related News: The Shanghai Institute of Materia Medica is under the Chinese Academy of Sciences (CAS), a top government think tank. The Wuhan Institute of Virology is also administered by the CAS and is among the country’s most advanced virus research laboratories.2,4-Difluoronitrobenzene manufacturer “Our collaboration with Mankind demonstrates our commitment towards providing novel, innovative treatment options for efficient diabetes management,” Glenmark Pharmaceuticals President, India Formulations, Middle East and Africa Sujesh Vasudevan said.3-(3-methyl-5-oxo-4H-pyrazol-1-yl)benzenesulfonic acid supplier “With early evidence of clinical activity for our off-the-shelf, iPSC-derived NK cell programs, we are excited to lead in bringing next-generation CAR T-cell therapies to patients and plan to submit an IND for FT819 in the first half of 2020.”Ethyl 2-Sulfamoylbenzoate vendor “With early evidence of clinical activity for our off-the-shelf, iPSC-derived NK cell programs, we are excited to lead in bringing next-generation CAR T-cell therapies to patients and plan to submit an IND for FT819 in the first half of 2020.”With the speeding up of review and approval, the number of approved innovative drugs in China is about to usher in a year of blowout.